The peripheral embolization coils market size is projected to reach US$ 613.96 million by 2031 from US$ 433.06 million in 2023. The market is expected to register a CAGR of 4.5% during 2023–2031. The growing importance of packing density is likely to remain a key trend in the peripheral embolization coils market.

Peripheral Embolization Coils Market Analysis

A rise in the prevalence of aortic aneurysms and an increase in the incidence of cancer are the key factors driving the peripheral embolization coils market. New product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Overview

Embolization procedures have become an integral part of interventional radiology treatments. A peripheral coil embolization system is used to treat vascular illnesses such as bleeding and trauma, aneurysms [arteriovenous malformations (AVMs)], tumors, and others. The platinum coil peripheral embolization system is most commonly used to treat extracerebral aneurysms and internal carotid aneurysms. An extracerebral aneurysm is a hemangioma that develops in one of the extracerebral arteries, such as the carotid or skull base artery. It is a common vascular abnormality that is prone to rupture, resulting in catastrophic complications such as stroke and hemorrhage.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Peripheral Embolization Coils Market: Strategic Insights

Peripheral Embolization Coils Market

• 
  CAGR (2023 - 2031)

  4.5%
• Market Size 2023
  US$ 433.06 Million
• Market Size 2031
  US$ 613.96 Million

Market Dynamics

GROWTH DRIVERS

• Rise in Prevalence of Aortic Aneurysm

FUTURE TRENDS

• Increase in Incidence of Cancer

OPPORTUNITIES

• Expanding Range of Applications of Embolization Coils

Key Players

• Medtronic Plc,
• Penumbra Inc.,
• Balt,
• Boston Scientific Corp,
• Cook Medical Holdings LLC,
• Wallaby Medical,
• Spartan Micro Inc.,
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD.,
• Terumo Corp,
• NeuroSafe Medical Co. Ltd.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Detachable Coil
• Pushable Coil

Material

• Platinum
• Platinum and Hydrogel
• Platinum Tungsten Alloy

Application

• Bleedings and Trauma
• Malformations
• Tumours
• Visceral Aneurysm
• Endoleak Type II
• Varicose Veins

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Peripheral Embolization Coils Market Drivers and Opportunities

Increase in Incidence of Cancer Favors Market Growth

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Expanding Range of Applications of Embolization Coils to Create Notable Opportunities in Future

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approvals, which help them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below.

In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy.

Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Peripheral Embolization Coils Market Report Segmentation Analysis

Key segments that contributed to the derivation of the peripheral embolization coils market analysis are type, material, and application.

• By type, the market is bifurcated into pushable coil and detachable coil. In 2023, the detachable coil segment held a larger share of the market.
• Based on material, the peripheral embolization coils market is segmented into platinum, platinum and hydrogel, and platinum tungsten alloy. In 2023, the platinum segment held the largest share of the market and is estimated to register the highest CAGR during the forecast period.
• By application, the market is divided into bleeding and trauma, malformations, tumors, visceral aneurysms, endoleak type II, and varicose veins. In 2023, the bleeding and trauma segment held the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period.

Peripheral Embolization Coils Market Share Analysis by Geography

The geographic scope of the peripheral embolization coils market report encompasses five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Europe dominated the peripheral embolization coils market in 2023. An upsurge in the prevalence of colorectal cancer and trauma is a prime factor propelling market growth in this region. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation.

Peripheral Embolization Coils Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Peripheral Embolization Coils Market News and Recent Developments

The peripheral embolization coils market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are mentioned below:

• Zylox-Tonbridge Medical Technology Co., Ltd. received marketing approval for its ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System from the National Medical Products Administration (NMPA). ZYLOX Phoenix is a proprietary medical device independently developed by the company for the minimally invasive interventional treatment of peripheral arterial embolism. (ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO LTD., Press Release, January 2024)
• Boston Scientific Corporation received US Food and Drug Administration (FDA) 510(k) clearance for the EMBOLD Fibered Detachable Coil, which is indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. (Coloplast Group, Press Release, April 2022)
• Wallaby Medical announced the acquisition of phenox GmbH—including femtos GmbH (femtos), a Germany-based global innovation and technology leader in the neurovascular space. The acquisition has been one of the world’s largest cross-border transactions in the medical device industry in recent years. It would enable the combined company to leverage the broad geographic coverage and product portfolio of participant companies to become a global leader in providing a wide range of neurovascular technologies and solutions to its customers and patients in the US, China, Europe, Japan, and other international markets. (Wallaby Medical, Press Release, April 2022)
• Wallaby Medical Holding, Inc. received approval from the National Medical Products Administration (NMPA) to market its Avenir Plus Coil System in China. The product was developed independently by Wallaby with the objective of safely and efficiently achieving a dense packing of aneurysms, isolating them from blood flow, and lowering the risk of future rupture or re-rupture. Smaller, softer coils included in the new Avenir Plus Coil System assist physicians in achieving such dense packing. (Wallaby Medical, Press Release, April 2022)

Peripheral Embolization Coils Market Report Coverage and Deliverables

The “Peripheral Embolization Coils Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

• Peripheral embolization coils market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Peripheral embolization coils market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Peripheral embolization coils market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the peripheral embolization coils market
• Detailed company profiles